Variant report
Variant | esv20492 |
---|---|
Chromosome Location | chr8:4953041-4962888 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140611359 | chr8:4958050-4958051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549773704 | chr8:4958055-4958056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185950288 | chr8:4958077-4958078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1377878 | chr8:4958092-4958093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541602776 | chr8:4958097-4958098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73505387 | chr8:4958107-4958108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs374482152 | chr8:4958109-4958110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559528009 | chr8:4958111-4958112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192035747 | chr8:4958112-4958113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570592577 | chr8:4958122-4958123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62489553 | chr8:4958124-4958125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76204212 | chr8:4958127-4958128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183976318 | chr8:4958131-4958132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574803604 | chr8:4958133-4958134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536101051 | chr8:4958135-4958136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs1377879 | chr8:4958139-4958140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs371115966 | chr8:4958141-4958142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572641766 | chr8:4958162-4958163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144613479 | chr8:4958184-4958185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372179261 | chr8:4958188-4958189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546066760 | chr8:4958195-4958196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114195176 | chr8:4958200-4958201 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375599678 | chr8:4958202-4958203 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576170823 | chr8:4958218-4958219 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543451077 | chr8:4958220-4958221 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs117368020 | chr8:4958255-4958256 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528877142 | chr8:4958269-4958270 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188518166 | chr8:4958270-4958271 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559368801 | chr8:4958274-4958275 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533178423 | chr8:4958279-4958280 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149094061 | chr8:4958285-4958286 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79687600 | chr8:4958293-4958294 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570630876 | chr8:4958304-4958305 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115615523 | chr8:4958349-4958350 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1377880 | chr8:4958358-4958359 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | mRNA abundance |
36 | rs535473271 | chr8:4958361-4958362 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115157371 | chr8:4958397-4958398 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564375407 | chr8:4962624-4962625 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
39 | rs533016337 | chr8:4962631-4962632 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536633801 | chr8:4962648-4962649 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35964505 | chr8:4962660-4962661 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
42 | rs118133399 | chr8:4962666-4962667 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
43 | rs76557636 | chr8:4962668-4962669 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544027768 | chr8:4962698-4962699 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575385067 | chr8:4962707-4962708 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
46 | rs150090253 | chr8:4962709-4962710 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
47 | rs181141771 | chr8:4962724-4962725 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144186353 | chr8:4962725-4962726 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
49 | rs555593069 | chr8:4962733-4962734 | Flanking Bivalent TSS/Enh | n/a | n/a | Overlapped CNVs | n/a |
50 | rs73507309 | chr8:4962751-4962752 | Flanking Bivalent TSS/Enh | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4958000-4958200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr8:4958200-4958400 | Bivalent Enhancer | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr8:4962600-4962800 | Flanking Bivalent TSS/Enh | iPS DF 6.9 Cell Line | embryonic stem cell |